Cancer survivors face the possibility that cancer will come back after treatment. Clinical trials are studies that help researchers learn more to help slow, manage, and treat cancer, as well as prevent cancer recurrence. If you have had bladder cancer, you can volunteer for a bladder cancer prevention clinical trial that is studying encapsulated rapamycin (eRapa) and its ability to reduce the risk of bladder cancer recurrence. This trial is led by researchers across Texas, including UT Health San Antonio, UT Southwestern Medical Center, and South Texas Veterans Health Care System, to explore new ways to prevent bladder cancer from coming back. “Unfortunately, people who’ve had bladder cancer have a high risk of developing a second bladder cancer,” said Dr. Amelie ...
When it comes to triple negative breast cancer, Ricki Fairley is a veteran on the battlefield. “I am a 10-year survivor of triple negative breast cancer. My doctor gave me two years to live, and I'm on 10,” Fairley said. Fairley is the CEO and co-founder of TOUCH—the Black Breast Cancer Alliance. She is determined to diversify clinical trials, which can help find better therapies for Black, Latino, and other people of color. “I'm really on a path, a mission to eradicate Black breast cancer and really change the game on how we talk to Black women about clinical trials. And right now, we only have 3% participation in clinical trials. So, the drugs that are currently on the market and the ...
Each year, more than 14,000 people are diagnosed with cervical cancer in the United States. This cancer is especially hurting communities of color, with Latinas at a high risk of a diagnosis. But cervical cancer is preventable. Stopping cervical cancer for Latinas and all communities means equitable education about the causes, prevention, and treatment of HPV and cervical cancer. Join #SaludTues at 1 p.m. EST on Jan. 4, 2022, to tweet about how we can stop cervical cancer in celebration of Cervical Cancer Awareness Month in January. WHAT: #SaludTues Tweetchat: “What Can We Do to Stop Cervical Cancer?”
DATE: Tuesday, Jan. 4, 2022
TIME: 1:00-2:00 p.m. EST (10:00-11:00 p.m. PST)
WHERE: On Twitter with hashtag #SaludTues
HOST: @SaludAmerica
CO-HOSTS: ...
Stomach cancer, also called gastric cancer, disproportionately impacts Latinos. In fact, U.S. Latino men and women are twice as likely as their White peers to develop invasive gastric cancer, according to a 2021 report. But little is known about regional differences. That is why Dr. Dorothy Long Parma of UT Health San Antonio and her colleagues conducted a study to analyze gastric cancer rates for Latinos in South Texas, Texas, and the United States. "We found that overall stomach cancer incidence rates in Texas and South Texas were higher in Latinos than in non-Latino Whites, despite lower frequencies in the state and South Texas region compared to the United States," said Long Parma, assistant professor/research at the Institute for Health Promotion Research (IHPR) in the ...
The patient economic burden for cancer in the U.S. was $21.09 billion, according to the Annual Report to the Nation on the Status of Cancer in JNCI: The Journal of the National Cancer Institute. “[This total is] made up of patient out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion,” according to the annual report. As technology, cancer research, and medicine advances, the effectiveness of therapy treatments only seem to proliferate. Though this is good news, the reality is that modern cancer treatments are a financial burden to people of color, who also face barriers to equitable cancer care. Latinos in particular face obstacles such as poor health literacy, concerns about test efficacy, and language and cultural beliefs related to cancer, ...
For Latino men, prostate cancer is the most common cancer diagnosis. While there is good news—from 2014-2018, Latino men were 20% less likely to face a prostate cancer diagnosis than their white peers—Latino men are more likely than their white peers to be diagnosed at a younger age, and with a higher risk of disease. This is why researchers at UT Health San Antonio are conducting the Prostate Active Surveillance Study (PASS) Clinical Trial in partnership with the Canary Foundation, a nonprofit dedicated to the early detection of cancer. The study is for men age 21 and older who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes ...
Dr. Amelie G. Ramirez, director of Salud America! at UT Health San Antonio and a leading health disparities researcher, will serve as the 2021-2022 chair of the the Women in Cancer Research Council of the American Association for Cancer Research (AACR). The council organizes the activities of the members of the Women in Cancer Research group. This includes fostering career development, recognizing scientific achievements, and advising AACR leadership. Ramirez is currently serving a three-year term on the council through December 2022. "It is a great honor to serve as Chair of the Women in Cancer Research (WICR) Council for the 2021-2022 term. Despite the challenges we have seen during the pandemic, I am proud to say women in science are still making strides and progressing in the ...
Cancer can affect anyone. But Latinos experience higher rates of infection-related cancers, ones that are preventable, than their white peers, according to a new study from the American Cancer Society (ACS). In fact, Latinos suffer two times higher rates of liver and stomach cancers—infection-related but preventable cancers—than their white peers. “Addressing this critical gap for Hispanic individuals in obtaining access to high-quality cancer prevention, early detection and treatment is going to be essential for mitigating the predicted growth in the cancer burden,” wrote Kimberly Miller, an ACS scientist, in the report. “In addition, more research is needed to assess not only the impact of the COVID-19 pandemic on the utilization of cancer care, but also the impact ...
Medicine, radiation, chemotherapy, and surgery are common ways to treat breast cancer. Researchers are also exploring new, possibly better treatments and procedures in breast cancer clinical trials, which are carefully controlled research studies. In some cases, clinical trials may be the only way to get access to newer treatments. If you have breast cancer, you can find a new option for treatment by volunteering for the Evaluation of Cryotherapy and TRPA1 Receptors in Chemotherapy Induced Neuropathy at Mays Cancer Center at UT Health San Antonio. Cryotherapy uses extreme cold to freeze and kill cancer cells and control pain. The trial, for women ages 18 and older, including Latinas, aims to better treat women who are suffering at the hands of breast cancer. “It’s ...
